PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

CELLTRION Inc

Request a quoteClaim this profile
Registered sites
1
Drug products
32
Live patents
0
Countries
1
Base
South Korea
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

1
SiteLocationOperationsFEI
CELLTRION Inc22014South KoreaAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3005241015
Catalogue

Marketed products

32

Showing 32 of 32.

BrandGeneric nameFormCategory
AVTOZMAtocilizumabINJECTION, SOLUTIONBLA
AVTOZMAtocilizumabINJECTION, SOLUTIONBLA
AVTOZMAtocilizumabINJECTION, SOLUTIONBLA
AVTOZMAtocilizumabINJECTION, SOLUTIONBLA
Adalimumabadalimumab-aatyKITBLA
Adalimumabadalimumab-aatyKITBLA
Adalimumabadalimumab-aatyKITBLA
-Adalimumab-aatyLIQUIDBULK INGREDIENT
Denosumab-BMWOdenosumab-bmwoINJECTIONBLA
Denosumab-BMWOdenosumab-bmwoINJECTIONBLA
Osenveltdenosumab-bmwoINJECTIONBLA
STEQEYMAustekinumab-stbaINJECTION, SOLUTIONBLA
STEQEYMAustekinumab-stbaINJECTION, SOLUTIONBLA
STEQEYMAustekinumab-stbaINJECTION, SOLUTIONBLA
STEQEYMAustekinumab-stbaINJECTION, SOLUTIONBLA
Stoboclodenosumab-bmwoINJECTIONBLA
Vegzelmabevacizumab-adcdINJECTION, SOLUTIONBLA
Vegzelmabevacizumab-adcdINJECTION, SOLUTIONBLA
Yuflymaadalimumab-aatyKITBLA
Yuflymaadalimumab-aatyKITBLA
ZYMFENTRAinfliximab-dyybINJECTIONBLA
-adalimumab-aatyINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-adalimumab-aatyINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-adalimumab-aatyINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-adalimumab-aatyINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-adalimumab-aatyINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-bevacizumab-adcdINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-bevacizumab-adcdINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-infliximab-dyybINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-infliximab-dyybINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBULK INGREDIENT
-infliximab-dyybINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-infliximab-dyybINJECTIONBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.